Join to View Full Profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6161
Fax+1 713-563-2366
Dr. Lin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins UniversityResidency, Radiation Oncology, 2005 - 2009
Loma Linda University Health Education ConsortiumInternship, Internal Medicine, 2004 - 2005
University of California, Irvine, School of MedicineClass of 2004
Certifications & Licensure
FL State Medical License 2021 - Present
CA State Medical License 2006 - 2027
GA State Medical License 2023 - 2027
TX State Medical License 2009 - 2027
AZ State Medical License 2023 - 2026
LA State Medical License 2023 - 2026
MS State Medical License 2023 - 2026
American Board of Radiology Radiation Oncology- Join now to see all
Clinical Trials
- Trimodality Management of T1b Esophageal Cancers Start of enrollment: 2010 Oct 01
- A Phase II Study of Minocycline and Armodafinil for Reducing the Symptom Burden Produced by Chemoradiation Treatment for Esophageal Cancer Start of enrollment: 2013 Feb 01
- Trametinib, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery Start of enrollment: 2013 Oct 28
- Join now to see all
Publications & Presentations
PubMed
- Dose to the left ventricle is associated to the risk of acute cardiac toxicity in patients with esophageal cancer undergoing trimodality treatment.Pieter Populaire, Gilles Defraene, Yuting Liu, Uwe Titt, Pablo Yepes
Radiotherapy and Oncology. 2025-08-01 - Outcomes and Toxicity following 3 or More Definitive Courses of Thoracic Radiation Therapy for Non-Small Cell Lung Cancer.Abigael Odwuor, Percy Lee, Joe Y Chang, Saumil Gandhi, Zhongxing Liao
Clinical Lung Cancer. 2025-07-01 - Impacts of Radiation on Metabolism and Vascular Cell Senescence.Junichi Abe, Khanh Chau, Anahita Mojiri, Guangyu Wang, Masayoshi Oikawa
Antioxidants & Redox Signaling. 2025-07-01
Journal Articles
- Recurrence Risk Based on Pathologic Stage After Neoadjuvant Chemoradiotherapy in Esophageal Squamous Cell Carcinoma: Implications for Risk-Based Postoperative Surveill...Hong Yang, Steven H Lin, Annals of Surgical Oncology
- Does Proton Therapy Offer Demonstrable Clinical Advantages for Treating Thoracic Tumors?☆Zhongxing Liao, Saumil J Gandhi, Steven H Lin, ScienceDirect
Press Mentions
BeyondSpring Inc. Reports Promising Results of Plinabulin Combination Therapy in Patients Refractory to Immune Checkpoint InhibitorsJuly 7th, 2025- BeyondSpring Publishes Human Clinical Study in Med (Cell Press) Showing Plinabulin-Driven Dendritic Cell Maturation and Tumor Response After Prior Checkpoint Inhibitor FailureJuly 7th, 2025
- MD Anderson Research Highlights for April 17, 2025April 17th, 2025
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
